Overview

Celecoxib for Pediatric Adenotonsillectomy

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The investigators' study will involve the administration of either placebo or celecoxib to children aged 2 to 18 years of age undergoing tonsillectomy and assessing pain relief, impact on quality of life and side effect profile.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Eastern Ontario
Collaborator:
University of Ottawa
Treatments:
Celecoxib